公司资料
Masimo 股价、新闻与催化剂
- 股票代码:
- MASI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
178.78 USD (+0.03%)
收盘价
最后更新: 2026年6月3日
9.36B USD
市值
股价为何变动
Current closing-price context is not available for MASI.
公司概览
业务概览
Masimo is a medical technology company focused on noninvasive monitoring, pulse oximetry, and connected healthcare devices. Its products are used in hospitals and consumer health settings for real-time patient monitoring.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Masimo has a global footprint in patient monitoring and consumer health. It sits in medtech rather than biotechnology.
商业模式特征
The company earns revenue through monitoring devices, consumables, and connected-health solutions. Investors follow product adoption, reimbursement, hospital penetration, and the role of consumer-health assets in the overall story.
生物医药行业定位
Masimo sits outside biotech but within the healthcare innovation stack. Its stock is driven by device adoption, technology execution, and litigation or strategic issues more than by drug events.
未来催化剂
- Masimo’s catalysts are hospital-monitoring adoption, consumer-health recovery, and continued rollout of the connected monitoring platform. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。